about
Female reproductive tract pain: targets, challenges, and outcomesVaginal drug distribution modelingRationale and Safety Assessment of a Novel Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release, Intended for Long-Term Protection of the Vaginal MicrobiomeContraception today.Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery.Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice.Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model.Nanoparticle-based drug delivery to the vagina: a review.Bioadhesive mini-tablets for vaginal drug delivery.Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine.Formulation and evaluation of clindamycin HCL in situ gel for vaginal application.Formulation, In Vitro and In Vivo Pharmacokinetics of Anti-HIV Vaginal Bioadhesive GelIn vivo distribution of surface-modified PLGA nanoparticles following intravaginal deliveryCervical cancer treatment with a locally insertable controlled release delivery system.Noninvasive routes of proteins and peptides drug delivery.Formulation, development and characterization of mucoadhesive film for treatment of vaginal candidiasisMonitoring vaginal epithelial thickness changes noninvasively in sheep using optical coherence tomography.The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemicsEnhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake.Contraceptive devices: intravaginal and intrauterine delivery systems.Non-Antiretroviral Microbicides for HIV Prevention.Comparing the effects of low-dose contraceptive pills to control dysfunctional uterine bleeding by oral and vaginal methods.Chitosan and its salts for mucosal and transmucosal delivery.Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes.Vaginal gel drug delivery systems: understanding rheological characteristics and performance.Vaginal mucoadhesive drug delivery systems.Innovations in bioadhesive vaginal drug delivery system.Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective.Impact of preformulation on drug development.Novel engineered systems for oral, mucosal and transdermal drug delivery.Advanced topical drug delivery system for the management of vaginal candidiasis.Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.Enhancing the buccal mucosal delivery of peptide and protein therapeutics.Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.Self-assembled nanoparticles made from a new PEGylated poly(aspartic acid) graft copolymer for intravaginal delivery of poorly water-soluble drugs.Vaginal suppositories containing Lactobacillus acidophilus: development and characterization.Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms.Potential Use of Alginate-Based Carriers As Antifungal Delivery SystemDegradable bioadhesive nanoparticles for prolonged intravaginal delivery and retention of elvitegravir.
P2860
Q27010296-828B3096-A460-455E-9EE2-81070608408DQ28088306-B6660F99-84A4-47F5-BD95-22C2CDEA8A83Q28551446-DF303565-0835-4D1F-9A03-C9AD157610DAQ30359932-5ED2816B-E963-43F6-8BB2-E07BEC12E887Q30478934-33D5C697-126F-4DE5-8E0C-99A6EC8B5C65Q33857681-A5F50B61-310C-499D-A8B7-33BB3D3DE8DCQ33911059-4AA1220E-D2B9-4E86-BA45-9A26C13D22C2Q33986007-C6742435-A602-4637-BB9F-9B11C175DFF7Q34079533-595EDE54-DE40-492D-B1B4-F9C8B5D62D5DQ34309842-897148A5-F559-4D6E-9BD9-CC4787509DB1Q34353780-92078FAA-318B-4226-9B39-2B960F89E259Q34866164-B44CA363-3BBA-421E-BD0E-DAFAF0C9F18FQ35064834-84B28364-8F32-4BD4-8582-24821DA88D37Q35563449-24693239-73C6-47FB-B0FE-2C9F8C16633FQ35585268-CABF1A04-6AA5-45D0-9E7F-C2E0DD71134EQ36029817-B8719A99-0BCF-409B-A09B-D2D032522596Q36675664-48523162-6B73-4B60-A5BF-EC1E7E9ABB2BQ36724657-B130BFA7-8B96-4192-B457-FF9D067ACADBQ36749580-0B4FDC1A-996E-4750-AE01-E229B7BB7A2FQ37158237-5430D632-23E3-4AE6-A45E-04D17D0AE0DFQ37273777-879E965F-BC96-4A4E-A231-15E538FF0552Q37317845-81071A31-D8AB-4A9A-89BC-0F1DA1B0131DQ37382701-AC6C3681-B810-4ADB-A7F1-A898637FF6D3Q37564537-40D8275B-E06E-4634-B6DE-43594E49698CQ37721812-1049B60D-CB90-4AD9-A21A-2C7DB1CDC92FQ37897568-3AB61D47-AF19-4618-BF2E-44B5A482D2A9Q37945742-6DEF31AA-DB12-4E89-B9FF-0C0120D166C6Q38031890-441E3AE0-AE94-4AC3-88F3-EB06AE724B90Q38066148-AC959C4B-D5BB-45F8-9B6D-D30301A7515FQ38093663-3E7A96F6-32AE-4B7D-818D-C09A5A2473A8Q38122744-B47F84C7-739E-41CF-82D8-D76B9F6B7753Q38222794-E71ED1D7-6312-40DB-A80C-16A7BC75A044Q38222809-01888CC8-1F7B-48C6-8BA7-8481190414DCQ38244323-66541D33-5E10-42D2-A76B-6CAF0CFFD322Q38260862-F48F0336-5D73-4FB8-B266-0C67F7E346DAQ38693808-08C11F32-81B6-48FC-BB69-273772CEA724Q38952328-A1FDBF3B-51EB-4A71-934D-BB800D4B1F60Q39124283-44DE189D-2A5D-47B4-A50A-C307B9EEC8A0Q39134282-3FBAC239-1E9E-4319-8681-C36B55B7EB95Q40075268-93029F22-08FF-471E-9286-EDD0BC751A6D
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
The vagina as a route for systemic drug delivery.
@ast
The vagina as a route for systemic drug delivery.
@en
The vagina as a route for systemic drug delivery.
@nl
type
label
The vagina as a route for systemic drug delivery.
@ast
The vagina as a route for systemic drug delivery.
@en
The vagina as a route for systemic drug delivery.
@nl
prefLabel
The vagina as a route for systemic drug delivery.
@ast
The vagina as a route for systemic drug delivery.
@en
The vagina as a route for systemic drug delivery.
@nl
P1476
The vagina as a route for systemic drug delivery.
@en
P2093
Alamdar Hussain
Fakhrul Ahsan
P304
P356
10.1016/J.JCONREL.2004.11.034
P407
P577
2005-01-13T00:00:00Z